Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 51.3B | 55.7B | 53.8B | 65.1B |
Cost of revenue | 14.5B | 15.1B | 15.9B | 14.9B |
Gross profit | 36.7B | 40.5B | 37.9B | 50.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 7.5B | 7.3B | 7.2B | 6.9B |
Other operating expenses | 10.1B | 10.3B | 8.7B | 10.4B |
Operating income | 19.1B | 22.9B | 22.0B | 32.9B |
Non operating interest income | ||||
Income | 603M | 709M | 529M | 81M |
Expense | 1.9B | 2.2B | 2.1B | 1.1B |
Other income expense | 507M | -5.4B | 1.1B | 1.3B |
Pretax income | 18.4B | 16.0B | 21.4B | 33.1B |
Tax provision | 7.2B | 6.4B | 7.1B | 10.7B |
Net income | 11.1B | 9.6B | 14.3B | 33.1B |
Basic EPS | 3.6 | 3.1 | 5.1 | 12.2 |
Diluted EPS | 3.5 | 3.1 | 5.1 | 12.2 |
Basic average shares | 2.5B | 2.5B | 2.5B | 2.5B |
Diluted average shares | 2.5B | 2.5B | 2.5B | 2.5B |
EBITDA | 25.9B | 26.6B | 28.5B | 38.9B |
Net income from continuing op. | 18.4B | 16.0B | 21.4B | 33.1B |
Minority interests | -2.1B | -1.7B | -1.4B | -2.2B |
Preferred stock dividends | — | — | — | — |